Stockscreener 앱 받기
1.69
1.81%
0.03
시간 외 거래:
1.72
0.03
+1.78%
Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스
H.C. Wainwright reiterates Caribou Biosciences stock rating at buy - Investing.com
Longer-term CB-011 results unveiled by Caribou Biosciences at EHA2026 - Traders Union
Caribou Biosciences (CRBU) Slides 3.92%, Nears Critical Support at $1.51Catalyst Driven Stocks - newsline.com
Caribou Biosciences, Inc. (CRBU) Presents at European Hematology Association (EHA) 2026 CongressSlideshow - Seeking Alpha
Caribou Biosciences presents new data on allogeneic CAR-T cell programs at EHA - Traders Union
Citi Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026 - Investing News Network
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association Annual Meeting - Investing News Network
Caribou reports phase 1 trial data for off-the-shelf CAR-T therapy - Investing.com UK
Caribou reports phase 1 data for off-the-shelf CAR-T therapy - Investing.com UK
Caribou reports phase 1 data for off-the-shelf CAR-T therapy By Investing.com - Investing.com Australia
Caribou Biosciences Highlights Strong Allogeneic CAR-T Trial Results - TipRanks
CB-011 dose escalation data points to advances in relapsed multiple myeloma, Caribou Biosciences launches study update - Traders Union
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting - The Manila Times
Caribou Biosciences (CRBU) reports durable phase 1 CAR-T responses in lymphoma and myeloma - Stock Titan
Off-the-shelf lymphoma cell therapy shows 82% response in early trial - Stock Titan
Caribou Biosciences Says CRISPR CAR-T Is Pivotal-Ready, CB-011 Data Nears - Yahoo Finance
Caribou Biosciences (CRBU) Declines 7% as Key Support Level ApproachesVolatility Smirk - newsline.com
Caribou Biosciences advances CRISPR-based CAR-T... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
Caribou Biosciences | DEFA14A: Others - Moomoo
CRBU Technical Analysis | Trend, Signals & Chart Patterns | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU) - ChartMill
CRBU DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Caribou Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 24 Deadline in Securities Class ActionCRBU - TMX Newsfile
Analyst Raises Caribou Biosciences Price Target Following Strong Results - asatunews.co.id
H.C. Wainwright Raises Caribou Biosciences Stock Price Target to $11 - HarianBasis.co
Caribou Biosciences (CRBU) Gets A Higher Target As Confidence In Its Pipeline Grows - Yahoo Finance
Caribou Biosciences (CRBU) Edges Higher as Stock Tests Key Resistance LevelsBPI Reversal - newsline.com
Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference - Investing News Network
Caribou Biosciences prepares to attend Jefferies Global Healthcare Conference in New York - Traders Union
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $11 - Moomoo
CRBU SEC FilingsCaribou Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
CRBU: Allogeneic CAR T programs show strong clinical progress and are advancing toward pivotal trials - TradingView
Caribou Biosciences stock (US1420381089): Q1 update and CRISPR pipeline stay in focus - AD HOC NEWS
CRBU Technical Analysis & Stock Price Forecast - Intellectia AI
Caribou Biosciences brings CMO and CFO to BioConnect Investor Conference fireside chat - Traders Union
Caribou Biosciences stock (US1420381089): fresh data from latest CAR?T update keeps investors watchi - AD HOC NEWS
Transcript : Caribou Biosciences, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 08 - marketscreener.com
Caribou Biosciences (CRBU) price target increased by 38.57% to 12.37 - MSN
Caribou Biosciences stock (US1420381089): Q1 earnings beat and 4.4% surge - AD HOC NEWS
May 2026's Promising Penny Stocks - Yahoo Finance
Bank of America Securities Remains a Buy on Caribou Biosciences (CRBU) - The Globe and Mail
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference - Investing News Network
Caribou Biosciences attends BioConnect Investor Conference in New York next week - Traders Union
CRISPR biotech Caribou Biosciences plans H.C. Wainwright talk May 19 - Stock Titan
Need To Know: Analysts Are Much More Bullish On Caribou Biosciences, Inc. (NASDAQ:CRBU) Revenues - simplywall.st
Industry Analysts Just Upgraded Their Caribou Biosciences, Inc. (NASDAQ:CRBU) Revenue Forecasts By 30% - Moomoo
Industry Analysts Just Made A Massive Upgrade To Their Caribou Biosciences, Inc. (NASDAQ:CRBU) Revenue Forecasts - Yahoo Finance
Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association Annual Meeting - Investing News Network
EHA2026 spotlights Caribou Biosciences advances in allogeneic CAR-T treatments for lymphoma and multiple myeloma - Traders Union
Caribou Biosciences, Inc. Announces Acceptance of Two Oral Presentations at the 2026 European Hematology Association Annual Meeting - Quiver Quantitative
Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting - The Manila Times
Caribou Biosciences CEO Rachel Haurwitz to join Bank of America conference fireside chat - Traders Union
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Raises Target Price to $11 - Moomoo
Caribou Biosciences (CRBU) Gets a Buy from Citi - The Globe and Mail
Q4 EPS Forecast for Caribou Biosciences Lowered by Analyst - MarketBeat
MSN Money - MSN
1.27%
1.43%
자본화:
|
볼륨(24시간):